Magazine cover article—“Combating corrosion in the world’s nuclear reactors”—features PNNL research leaders Mark Nutt, Aaron Diaz, and Mychailo Toloczko.
PNNL’s Steven Spurgeon, a materials scientist, was recently elected leader of the Microscopy Society of America (MSA) aberration-corrected microscopy focused interest group.
Twelve researchers from PNNL presented at the 2020 Metabolomics Association of North America virtual conference in mid-September. Their presentations included a plenary talk, keynote talks, oral presentations, posters, and a lightning talk.
Pacific Northwest National Laboratory (PNNL) is part of a continuing National Science Foundation (NSF) team investigating the environmental impact of nanoparticles at the molecular level.
A cadre of physical scientists, engineers and computing experts at Pacific Northwest National Laboratory is poised to participate in the launch of three new DOE Office of Science-sponsored quantum information science research centers.
A new radiation-resistant material for the efficient capture of noble gases xenon and krypton makes it safer and cheaper to recycle spent nuclear fuel.
Researchers from PNNL have helped colleagues at OHSU identify lipid molecules required for Zika infection in human cells. The specific lipids involved could also be a clue to why the virus primarily infects brain tissue.
International editing team provided 15-year update, with Devanathan focused on intersection of nuclear science, materials science, and multiscale modeling.
Researchers from 25 institutions around the country, including PNNL, are working to find out how exercise changes the molecular makeup of our cells to generate health benefits.
Materials Scientist Arun Devaraj has been selected among 76 recipients nationwide to receive a 2020 Early Career Research Program award from the U.S. Department of Energy
After 50 years in science and on the eve of retirement, Laboratory Fellow Karin Rodland, a cancer cell biologist at PNNL, is working on experiments she has dreamed about for decades.
Accurate identification of metabolites, and other small chemicals, in biological and environmental samples has historically fallen short when using traditional methods.
A new study using proteogenomics to compare cancerous tissue with normal fallopian tube samples advances insights about the molecular machinery that underlies ovarian cancer.
